...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Functional effects of beta(3)-adrenoceptor on pacemaker activity in interstitial cells of Cajal from the mouse colon
【24h】

Functional effects of beta(3)-adrenoceptor on pacemaker activity in interstitial cells of Cajal from the mouse colon

机译:β(3)-肾上腺素受体对小鼠结肠Cajal间质细胞起搏器活动的功能影响

获取原文
获取原文并翻译 | 示例
           

摘要

We investigated the presence of beta(3)-adrenoceptor and its functional effects on pacemaker potentials in colonic interstitial cells of Cajal (ICCs) from mice. The whole cell patch clamp technique was used to record pacemaker potentials in cultured ICCs and reverse transcription polymerase chain reaction (RT-PCR) was performed to detect the mRNA transcript levels beta-adrenoceptors. The beta(3)-adrenoceptor agonist, BRL37344, reduced the frequency of pacemaker potentials in a Concentration dependent manner. The inhibitory effects of BRL37344 wore blocked by the pretreatment of propranolol, a nonspecific beta-adrenoceptor antagonist, but not by the selective beta(1)-adrenoceptor antagonist atenolol and the selective beta(2)-adrenoceptor antagonist butoxamine. beta(3)-adrenocepto antagonists SR59230A and L748337 blocked the inhibitory effects of BRL37344. RT-PCR revealed mRNA transcripts of beta(1)- and beta(3)-adrenoceptor, but not beta(2)-adrenoceptor, in c-kit- and Ano-1-positive colonic ICCs. The K+ channel blockers tetraethylammoniu, apamin, and glibenclamide did not block the effects of BRL37344. N-omega-Nitio-L-arginiue methyl ester hydrochloride (L-NAME), an NO synthase inhibitor, and chelerythrine, a protein Kinase C inhibitor, also did not block the effects of BRL37344. Noradrenaline mimicked the effects of BRL37344 in colonic ICCs. However, the inhibitory effects of noradrenaline on pacemaker potentials were blocked only by pretreatment with atenolol but not by butoxamine, SR59230A, or L748337 in small intestinal ICCs, BRL37344 had no effect On pacemaker potentials and mRNA transcripts of beta(1)-and beta(2)-adrenoceptor, but not beta(3)-adrenoceptor were detected. These results suggest that beta(3)-adrenoceptors are present in colonic ICCs and may play a role in regulating gastrointestinal motility by the inhibition or pacemaker potentials. (C) 2015 Elsevier By. All rights reserved.
机译:我们调查了β(3)-肾上腺素能受体的存在及其对小鼠Cajal结肠间质细胞(ICCs)中起搏器电位的功能影响。使用全细胞膜片钳技术记录培养的ICC中的起搏器电位,并进行逆转录聚合酶链反应(RT-PCR)以检测mRNA转录水平β-肾上腺素受体。 β(3)-肾上腺素受体激动剂BRL37344以浓度依赖的方式降低了起搏器电位的频率。 BRL37344的抑制作用被普萘洛尔(一种非特异性β-肾上腺素受体拮抗剂)的预处理所阻断,但未被选择性β(1)-肾上腺素受体拮抗剂阿替洛尔和选择性β(2)-肾上腺素受体拮抗剂丁氧胺所阻止。 β(3)-肾上腺素能拮抗剂SR59230A和L748337阻断了BRL37344的抑制作用。 RT-PCR显示在c-kit-和Ano-1阳性结肠ICC中,beta(1)-和beta(3)-肾上腺素受体的mRNA转录物,而不是beta(2)-肾上腺素受体。 K +通道阻滞剂四乙铵,Apapamin和格列本脲不阻断BRL37344的作用。 NO合酶抑制剂N-ω-Nitio-L-精氨酸甲酯盐酸盐(L-NAME)和蛋白质激酶C抑制剂白屈菜红碱也没有阻止BRL37344的作用。去甲肾上腺素模拟了BRL37344在结肠ICC中的作用。然而,去甲肾上腺素对小心脏ICCs的起搏器电位的抑制作用只有通过阿替洛尔预处理而不能被丁氧胺,SR59230A或L748337阻断,BRL37344对起搏器电位和β(1)-和β( 2)-肾上腺素受体,但未检测到beta(3)-肾上腺素受体。这些结果表明,β(3)-肾上腺素能受体存在于结肠ICC中,并可能通过抑制或起搏器电位在调节胃肠道蠕动中发挥作用。 (C)2015 Elsevier By。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号